News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,967 Results
Type
Article (87029)
Company Profile (704)
Press Release (767222)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232897)
Career Advice (4133)
Deals (39769)
Drug Delivery (130)
Drug Development (91142)
Employer Resources (199)
FDA (18214)
Job Trends (17374)
News (396997)
Policy (39849)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1618)
Antibody-drug conjugate (ADC) (192)
Approvals (18169)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (105)
Brain cancer (44)
Breast cancer (412)
Cancer (3257)
Cardiovascular disease (261)
Career advice (3542)
Career pathing (34)
CAR-T (217)
CDC (43)
Cell therapy (599)
Cervical cancer (25)
Clinical research (74550)
Collaboration (1168)
Company closure (3)
Compensation (768)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (405)
Cystic fibrosis (125)
Data (3315)
Decentralized trials (2)
Denatured (55)
Depression (83)
Diabetes (389)
Diagnostics (7007)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (160)
Drug shortages (36)
Duchenne muscular dystrophy (166)
Earnings (98217)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131705)
Executive appointments (930)
FDA (20217)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1049)
Gene editing (154)
Generative AI (42)
Gene therapy (466)
GLP-1 (958)
Government (5297)
Grass and pollen (7)
Guidances (304)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (46)
Immunology and inflammation (196)
Immuno-oncology (15)
Indications (43)
Infectious disease (3123)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (132)
Interviews (813)
IPO (17908)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (62)
Layoffs (608)
Leadership (27)
Legal (10139)
Liver cancer (87)
Longevity (12)
Lung cancer (452)
Lymphoma (230)
Machine learning (16)
Management (65)
Manufacturing (490)
MASH (106)
Medical device (14765)
Medtech (14775)
Mergers & acquisitions (22629)
Metabolic disorders (994)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (47)
Neuroscience (2419)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (504)
Opinion (295)
Ovarian cancer (108)
Pain (132)
Pancreatic cancer (136)
Parkinson's disease (206)
Partnered (25)
Patents (346)
Patient recruitment (197)
Peanut (55)
People (65837)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22999)
Phase II (32368)
Phase III (24376)
Pipeline (1996)
Policy (260)
Postmarket research (3554)
Preclinical (10389)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (550)
Real estate (7402)
Recruiting (76)
Regulatory (27370)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (107)
Series A (175)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (97)
Vaccines (949)
Venture capital (62)
Weight loss (342)
Women's health (53)
Worklife (20)
Date
Today (2)
Last 7 days (769)
Last 30 days (2252)
Last 365 days (33714)
2025 (20506)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (72)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (50625)
Australia (8895)
California (8226)
Canada (2520)
China (757)
Colorado (352)
Connecticut (367)
Delaware (219)
Europe (116220)
Florida (1227)
Georgia (279)
Hawaii (3)
Idaho (67)
Illinois (763)
India (34)
Indiana (405)
Iowa (19)
Japan (249)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1156)
Massachusetts (6284)
Michigan (282)
Minnesota (515)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (88)
New Hampshire (74)
New Jersey (2291)
New Mexico (31)
New York (2268)
North Carolina (1285)
North Dakota (10)
Northern California (3596)
Ohio (264)
Oklahoma (17)
Oregon (48)
Pennsylvania (1751)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (37)
South Dakota (1)
Southern California (3074)
Tennessee (135)
Texas (1264)
United States (30883)
Utah (241)
Virginia (224)
Washington D.C. (80)
Washington State (716)
West Virginia (4)
Wisconsin (89)
There are 854,967 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
5 Oral Obesity Drugs Challenging Lilly’s Orforglipron
Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.
August 11, 2025
·
9 min read
·
Tristan Manalac
FDA
FDA Action Alert: Biogen/Eisai, Sanofi, Ionis and More
Arguably the FDA’s most anticipated decision this month is for a subcutaneous induction formulation of Biogen and Eisai’s Alzheimer’s drug Leqembi, which, according to Eisai, could “help reduce the burden on healthcare professionals and patients.”
August 11, 2025
·
5 min read
·
Tristan Manalac
FDA
Prasad Back at CBER After 10-Day California ‘Vacation’
After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for Biologics Evaluation and Research, HHS confirmed to several outlets Saturday.
August 9, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
August 8, 2025
·
10 min read
Press Releases
Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference
August 8, 2025
·
5 min read
Press Releases
Treace Medical Concepts Reports Second Quarter 2025 Financial Results
August 8, 2025
·
16 min read
Press Releases
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
August 8, 2025
·
14 min read
Press Releases
Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 8, 2025
·
9 min read
Press Releases
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
August 8, 2025
·
11 min read
Press Releases
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
August 8, 2025
·
1 min read
1 of 85,497
Next
